A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is a highly heterogeneous disease, for which prognosis has been relegated to clinicopathologic staging for decades. There is a need to stratify subpopulations of CRC on a molecular basis to better predict outcome and assign therapies. Here we report targeted exome-sequencing of 1,321 cancer-related genes on 468 tumour specimens, which identified a subset of 17 genes that best classify CRC, with APC playing a central role in predicting overall survival. APC may assume 0, 1 or 2 truncating mutations, each with a striking differential impact on survival. Tumours lacking any APC mutation carry a worse prognosis than single APC mutation tumours; however, two APC mutation tumours with mutant KRAS and TP53 confer the poorest survival among all the subgroups examined. Our study demonstrates a prognostic role for APC and suggests that sequencing of APC may have clinical utility in the routine staging and potential therapeutic assignment for CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Approximately 55% of colorectal cancers (CRCs) are driven by mutational activation of KRAS, BRAF, NRAS, and thus are hard-wired to oncogenic RAS/RAF/MEK/ERK pathway signaling [1–3].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · cited 3×
“Using the recently reported CMS classification system 36 , we found that CMS1, instead of CMS4 MSS tumours, were significantly associated with worse survival.”
InfluentialMicrosatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Cited by
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
Yaeger, R., Chatila, W. K., Lipsyc, M. D., Hechtman, J. F., Cercek, A., Sanchez-Vega, F., Jayakumaran, G., Middha, S., Zehir, A., Donoghue, M. T. A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.004 · Cited by 858
“In our model, we considered APC oncogenic alterations as a single group, but further analysis with larger datasets may be able to refine the positive prognostic effect of APC alterations, as recent data suggest that the number of APC alterations also affects survival (Schell et al., 2016).”
MethodMutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466
Lu, Y., Zhao, X., Liu, Q., Li, C., Graves-Deal, R., Cao, Z., Singh, B., Franklin, J. L., Wang, J., Hu, H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4424 · Cited by 425
Self-citationJung, Y.-S., & Park, J.-I. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0380-6 · Cited by 419
Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes
Lee, M. S., Menter, D. G., & Kopetz, S. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0038 · Cited by 379
Immunotherapy, Inflammation and Colorectal Cancer
Lichtenstern, C. R., Ngu, R. K., Shalapour, S., & Karin, M. (2020) · Cells · doi:10.3390/cells9030618 · Cited by 294
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Mechanisms of metastatic colorectal cancer
Cañellas-Socias, A., Sancho, E., & Batlle, E. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00934-z · Cited by 249
Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer
Lieu, C. H., Golemis, E. A., Serebriiskii, I. G., Newberg, J., Hemmerich, A., Connelly, C., Messersmith, W. A., Eng, C., Eckhardt, S. G., Frampton, G., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0899 · Cited by 233
Gajos-Michniewicz, A., & Czyz, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144852 · Cited by 222
Emerging organoid models: leaping forward in cancer research
Fan, H., Demirci, U., & Chen, P. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0832-4 · Cited by 199
“Consistent with previous clinical studies [39, 40], combinatorial genetic mutations of Kras, p53, Apc, and Smad4 in healthy colonic organoids gave rise to adenocarcinoma organoids, while normal gastric and pancreatic organoids can be transformed into the adenocarcinoma organoids after p53 loss, Kras expression or both…”
Nowak-Sliwinska, P., Scapozza, L., & Ruiz i Altaba, A. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.005 · Cited by 183
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
Westcott, P. M. K., Sacks, N. J., Schenkel, J. M., Ely, Z. A., Smith, O., Hauck, H., Jaeger, A. M., Zhang, D., Backlund, C. M., Beytagh, M. C., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00247-z · Cited by 175
Aghabozorgi, A. S., Bahreyni, A., Soleimani, A., Bahrami, A., Khazaei, M., Ferns, G. A., Avan, A., & Hassanian, S. M. (2019) · Biochimie · doi:10.1016/j.biochi.2018.11.003 · Cited by 144
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
Shah, K., & Kazi, J. U. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858782 · Cited by 135
Current and future biomarkers in colorectal cancer
Zarkavelis, G., Boussios, S., Papadaki, A., Katsanos, K. H., Christodoulou, D. K., & Pentheroudakis, G. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0191 · Cited by 119
Driver Gene Mutations and Epigenetics in Colorectal Cancer
Raskov, H., Søby, J. H., Troelsen, J. T., Bojesen, R. D., & Gögenür, I. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003393 · Cited by 107
Fleming-de-Moraes, C. D., Rocha, M. R., Tessmann, J. W., de Araújo, W. M., & Morgado‐Díaz, J. A. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2108690 · Cited by 101
Genetic and epigenetic dependencies in colorectal cancer development
Parmar, S., & Easwaran, H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac035 · Cited by 99
The Genomics of Colorectal Cancer in Populations with African and European Ancestry
Myer, P. A., Lee, J. K., Madison, R. W., Pradhan, K., Newberg, J. Y., Isasi, C. R., Klempner, S. J., Frampton, G. M., Ross, J. S., Venstrom, J. M., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0813 · Cited by 91
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
Petit, J. A., Carroll, G. M., Gould, T., Pockney, P. G., Dun, M. D., & Scott, R. J. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.11.029 · Cited by 88
Targeting regulation of tryptophan metabolism for colorectal cancer therapy: a systematic review
Zhang, H., Zhang, A., Miao, J.-H., Sun, H. J., Yan, G., Wu, F., & Wang, X. (2019) · RSC Advances · doi:10.1039/c8ra08520j · Cited by 98
An update on colorectal cancer microenvironment, epigenetic and immunotherapy
Jin, K., Ren, C., Liu, Y., Lan, H., & Wang, Z. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107041 · Cited by 90
Domingo, E., Camps, C., Kaisaki, P. J., Parsons, M. J., Mouradov, D., Pentony, M. M., Makino, S., Palmieri, M., Ward, R. L., Hawkins, N. J., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30117-1 · Cited by 76
Biomarkers in colorectal liver metastases
Yamashita, S., Chun, Y. S., Kopetz, S., & Vauthey, J. (2018) · British journal of surgery · doi:10.1002/bjs.10834 · Cited by 79
Nagahashi, M., Wakai, T., Shimada, Y., Ichikawa, H., Kameyama, H., Kobayashi, T., Sakata, J., Yagi, R., Sato, N., Kitagawa, Y., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0387-8 · Cited by 81
Evaluating somatic tumor mutation detection without matched normal samples
Teer, J. K., Zhang, Y., Chen, L., Welsh, E. A., Cress, W. D., Eschrich, S. A., & Berglund, A. (2017) · Human Genomics · doi:10.1186/s40246-017-0118-2 · Cited by 75
Self-citationAPC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review
Liang, T.-J., Wang, H.-X., Zheng, Y.-Y., Cao, Y.-Q., Wu, X., Zhou, X., & Dong, S.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.17576 · Cited by 70
Wierzbicka, A., Mańkowska‐Wierzbicka, D., Mardas, M., & Stelmach-Mardas, M. (2021) · Nutrients · doi:10.3390/nu13041160 · Cited by 72
Enhancing the landscape of colorectal cancer using targeted deep sequencing
Lee, C. S., Song, I. H., Lee, A., Kang, J., Lee, Y. S., Lee, I. K., Song, Y. S., & Lee, S. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-87486-3 · Cited by 64
Cross-Talk between p53 and Wnt Signaling in Cancer
Xiao, Q., Werner, J., Venkatachalam, N., Boonekamp, K. E., Ebert, M. P. A., & Zhan, T. (2022) · Biomolecules · doi:10.3390/biom12030453 · Cited by 62
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
Serebriiskii, I. G., Pavlov, V., Tricarico, R., Andrianov, G., Nicolas, E., Parker, M. I., Newberg, J., Frampton, G., Meyer, J. E., & Golemis, E. A. (2022) · Nature Communications · doi:10.1038/s41467-022-29227-2 · Cited by 55
Lipsyc-Sharf, M. D., Zhang, S., Ou, F., Ma, C., McCleary, N. J., Niedzwiecki, D., Chang, I.-W., Lenz, H., Blanke, C. D., Piawah, S., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab200 · Cited by 54
Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer
Zhong, Z. A., Michalski, M. N., Stevens, P. D., Sall, E. A., & Williams, B. O. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100782 · Cited by 52
Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer
Dong, L., & Ren, H. (2018) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000477 · Cited by 54
Kyrochristos, I. D., & Roukos, D. H. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101894 · Cited by 54
Li, C., Singh, B., Graves-Deal, R., Ma, H., Starchenko, A., Fry, W. H., Lu, Y., Wang, Y., Bogatcheva, G., Khan, M. P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618297114 · Cited by 47
Self-citationCELLector: Genomics-Guided Selection of Cancer In Vitro Models
Najgebauer, H., Yang, M., Francies, H. E., Pacini, C., Stronach, E. A., Garnett, M. J., Saez-Rodriguez, J., & Iorio, F. (2020) · Cell Systems · doi:10.1016/j.cels.2020.04.007 · Cited by 43
Self-citationZhu, S., Al‐Mathkour, M. M., Cao, L., Khalafi, S., Chen, Z., Poveda, J., Peng, D., Lu, H., Soutto, M., Hu, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112005 · Cited by 43
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer
Xu, T., Zhang, Y., Zhang, J., Qi, C., Liu, D., Wang, Z., Li, Y., Ji, C., Li, J., Lin, X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.568911 · Cited by 45
Li, T., Jian, X., He, H., Lai, Q., Li, X., Deng, D., Liu, T., Zhu, J., Jiao, H., Ye, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0879-z · Cited by 40
Self-citationRegenerative Engineering: Current Applications and Future Perspectives
Goldenberg, D., McLaughlin, C., Koduru, S. V., & Ravnic, D. J. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2021.731031 · Cited by 40
Wang, J., Li, R., He, Y., Yi, Y., Wu, H., & Liang, Z. (2020) · Modern Pathology · doi:10.1038/s41379-020-0612-2 · Cited by 38
Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer
Bala, P., Singh, A. K., Kavadipula, P., Kotapalli, V., Sabarinathan, R., & Bashyam, M. D. (2020) · Oncogene · doi:10.1038/s41388-020-01537-z · Cited by 40
Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer
Liu, M., Liu, Y., Di, J., Su, Z., Yang, H., Jiang, B., Wang, Z., Zhuang, M., Bai, F., & Su, X. (2017) · BMC Cancer · doi:10.1186/s12885-017-3777-4 · Cited by 38
The landscape of somatic mutation in sporadic Chinese colorectal cancer
Liu, Z., Yang, C., Li, X., Luo, W., Roy, B., Xiong, T., Zhang, X., Yang, H., Wang, J. Z., Ye, Z., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25287 · Cited by 36
Self-citationWild-typeAPCIs Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer
Wang, C., Ouyang, C., Cho, M. T., Ji, J., Sandhu, J. S., Goel, A., Kahn, M., & Fakih, M. (2020) · The Oncologist · doi:10.1002/onco.13607 · Cited by 38
Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer
Lee, Y., Dho, S. H., Lee, J., Hwang, J.-H., Kim, M., Choi, W., Lee, J.-Y., Lee, J. W., Chang, W., Lee, M. Y., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00731-1 · Cited by 34
Lefol, C., Sohier, E., Baudet, C., Naïbo, P., Ruano, E., Grand‐Masson, C., Viari, A., & Wang, Q. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-00778-6 · Cited by 32
Moshawih, S., Fern, L. A., Ardianto, C., Goh, K. W., Kifli, N., Goh, H. P., Jarrar, Q., & Ming, L. C. (2022) · Biomolecules · doi:10.3390/biom12070878 · Cited by 34
Mutation patterns in colorectal cancer and their relationship with prognosis
Su, Z., Hage, M. E., & Linnebacher, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36550 · Cited by 33
Dang, Q., Zuo, L., Hu, X., Zhou, Z., Chen, S., Liu, S., Ba, Y., Zuo, A., Xu, H., Weng, S., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70041 · Cited by 31
β-catenin in adrenal zonation and disease
Little, D. W., Dumontet, T., LaPensee, C. R., & Hammer, G. D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111120 · Cited by 32
Ghorbaninejad, M., Asadzadeh‐Aghdaei, H., Baharvand, H., & Meyfour, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121506 · Cited by 31
Davis, T. B., Yang, M., Schell, M. J., Wang, H., Ma, L., Pledger, W. J., & Yeatman, T. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27584-x · Cited by 27
Self-citationAkéus, P., Szeponik, L., Ahlmanner, F., Sundström, P., Alsén, S., Gustavsson, B. G., Sparwasser, T. D., Raghavan, S., & Quiding‐Järbrink, M. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2161-9 · Cited by 27
A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
Salvucci, M., Würstle, M. L., Morgan, C., Curry, S., Cremona, M., Lindner, A. U., Bacon, O., Resler, A. J., Murphy, Á. C., O’Byrne, R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1084 · Cited by 27
Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer
Kyrochristos, I. D., Ziogas, D. E., GOUSSIA, A. C., Glantzounis, G. K., & Roukos, D. H. (2019) · Cancers · doi:10.3390/cancers11111809 · Cited by 26
Lueong, S., Herbst, A., Liffers, S., Bielefeld, N., Horn, P., Tannapfel, A., Reinacher‐Schick, A., Hinke, A., Hegewisch‐Becker, S., Kolligs, F. T., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa223 · Cited by 25
de Voer, R. M., Diets, I. J., van der Post, R. S., Weren, R. D. A., Kamping, E. J., de Bitter, T. J. J., Elze, L., Verhoeven, R. H. A., Vink‐Börger, E. M., Eijkelenboom, A., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.034 · Cited by 25
APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes
Thota, R., Yang, M., Pflieger, L. T., Schell, M. J., Rajan, M., Davis, T. B., Wang, H., Presson, A. P., Pledger, W. J., & Yeatman, T. J. (2021) · Cancers · doi:10.3390/cancers13215394 · Cited by 23
Self-citationYang, M., Davis, T. B., Pflieger, L., Nebozhyn, M. V., Loboda, A., Wang, H., Schell, M. J., Thota, R., Pledger, W. J., & Yeatman, T. J. (2022) · BMC Cancer · doi:10.1186/s12885-022-09344-3 · Cited by 22
“The 2250 CRC tumors included a subset of 468 tumors we previously analyzed with global gene expression data, MSI status, and targeted gene sequencing of 1321 cancer-related genes [3, 4, 22].”
MethodInfluentialSelf-citationRepurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant APC and TP53 Subpopulations
Yang, M., Schell, M. J., Loboda, A. P., Nebozhyn, M., Li, J., Teer, J. K., Pledger, W. J., & Yeatman, T. J. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1383 · Cited by 23
Self-citationSiraj, A. K., Parvathareddy, S. K., Pratheeshkumar, P., Divya, S. P., Ahmed, S. O., Melosantos, R., Begum, R., Concepcion, R., Al-Sanea, N. A., Ashari, L. H. S., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109572 · Cited by 22
Ray, S. K., & Mukherjee, S. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666201211102710 · Cited by 24
Babaei‐Jadidi, R., Kashfi, H., Alelwani, W., Bakhtiari, A. K., Kattan, S. W., Mansouri, O. A., Mukherjee, A., Lobo, D. N., & Nateri, A. S. (2022) · Oncogenesis · doi:10.1038/s41389-021-00376-1 · Cited by 21
MED12is recurrently mutated in Middle Eastern colorectal cancer
Siraj, A. K., Masoodi, T., Bu, R., Pratheeshkumar, P., Al-Sanea, N. A., Ashari, L. H. S., Abduljabbar, A. S., Alhomoud, S. J., Al‐Dayel, F., Alkuraya, F. S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313334 · Cited by 20
Wang, C., Yue, Y., Shao, B., Qiu, Z., Mu, J., Tang, J., Han, X., Xiang, T., & Ren, G. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471861 · Cited by 20
Association of WNT Pathway Genes With Nonsyndromic Cleft Lip With or Without Cleft Palate
Vijayan, V., Ummer, R., Weber, R. J., Silva, R. M., & Letra, A. (2017) · The Cleft Palate-Craniofacial Journal · doi:10.1177/1055665617732782 · Cited by 20
Zhang, R., Hu, M. X., Chen, H., Wang, X., Xia, Z., Liu, Y., Wang, R., Xia, X., Yang, S., Du, D., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100532 · Cited by 20
Immunohistochemistry features and molecular pathology of appendiceal neoplasms
Mikaeel, R. R., Young, J. P., Rico, G. T., Hewett, P. J., Hardingham, J. E., Uylaki, W., Horsnell, M. E., & Price, T. J. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1881756 · Cited by 18
Dietinger, V., de Durango, C. G., Wiechmann, S., Boos, S. L., Michl, M., Neumann, J. H. L., Hermeking, H., Küster, B., & Jung, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00561-6 · Cited by 18
A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli
Zhang, Y., Liu, X., Li, A., & Tang, X. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265655 · Cited by 18
Hammarström, K., Nunes, L., Mathot, L., Mezheyeuski, A., Lundin, E., Hult, N. K., Imam, I., Österlund, E., Sjöblom, T., & Glimelius, B. L. G. (2024) · International Journal of Cancer · doi:10.1002/ijc.34880 · Cited by 17
Novel strategies for comprehensive mutation screening of the APC gene
Wachsmannová, L., Mego, M., Števurková, V., Zajac, V., & Čierniková, S. (2017) · Neoplasma · doi:10.4149/neo_2017_303 · Cited by 17
Shi, Q., Shen, L., Gan, J., He, L., Lin, J., Guo, S., Xiong, Z., Lin, J., & Zhang, S. (2019) · Epigenetics · doi:10.1080/15592294.2019.1588684 · Cited by 17
Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal Diseases
Jonaitis, P., Kiudelis, V., Streleckienė, G., Gedgaudas, R., Skiecevičienė, J., & Kupčinskas, J. (2021) · Digestive Diseases · doi:10.1159/000515522 · Cited by 19
A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
Hou, D., Tan, J.-N., Zhou, S., Xu, Y., Zhang, Z., Zhong, G., Zhong, L., Yang, B., & Han, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.969845 · Cited by 18
LFA-1 knockout inhibited the tumor growth and is correlated with treg cells
Niu, T., Li, Z., Huang, Y., Ye, Y., Liu, Y., Ye, Z.-J., Jiang, L., He, X., Wang, L., & Li, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01238-6 · Cited by 16
Shin, G. W., Greer, S., Hopmans, E. S., Grimes, S. M., Lee, H., Zhao, L., Miotke, L. K., Suarez, C. J., Almeda, A. F., Haraldsdóttir, S., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00958-z · Cited by 17
Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma
Riobello, C., Sánchez‐Fernández, P., Cabal, V. N., García‐Marín, R., Suárez–Fernández, L., Vivanco, B., Blanco‐Lorenzo, V., Marcos, C. Á., López, F., Llorente, J. L., et al. (2021) · Cancers · doi:10.3390/cancers13195022 · Cited by 16
Yan, H., Jiang, F., & Yang, J. (2022) · Genetics Research · doi:10.1155/2022/5338956 · Cited by 17
The genetic script of metastasis
Jinesh, G. G., & Brohl, A. S. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12562 · Cited by 17
Does school breakfast benefit children's educational performance?
Fernald, L. C. H., Ani, C. C., & Grantham‐McGregor, S. (1997) · PubMed · Cited by 18
Yin, T., Zhao, D., & Yao, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.679150 · Cited by 18
Chen, M., Xue, C., Huang, R., Ni, M., Lü, L., Li, H., Yang, W., Hu, A.-Q., Zheng, Z., An, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.739134 · Cited by 14
Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles
Matejcic, M., Teer, J. K., Hoehn, H. J., Díaz, D. B., Shankar, K., Gong, J., Nguyen, N. T., Lorona, N. C., Coppola, D., Fulmer, C. G., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-0747 · Cited by 16
Self-citationvan den Driest, L., Johnson, C. H., Rattray, N. J. W., & Rattray, Z. (2022) · Alternatives to Laboratory Animals · doi:10.1177/02611929221107546 · Cited by 13
Progression inference for somatic mutations in cancer
Peterson, L. E., & Kovyrshina, T. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00277 · Cited by 13
Abdul, S.-N., Mutalib, N. A., Khor, S. S., Syafruddin, S. E., Ishak, M., Sagap, I., Mazlan, L., Rose, I. M., Abu, N., Mokhtar, N. M., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00465 · Cited by 14
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer
Capalbo, C., Belardinilli, F., Raimondo, D., Milanetti, E., Malapelle, U., Pisapia, P., Magri, V., Prete, A. A., Pecorari, S., Colella, M., et al. (2019) · Cancers · doi:10.3390/cancers11020147 · Cited by 13
Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
Li, D., Lin, X., Chen, B., Ma, Z., Zeng, Y., & Wang, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.723802 · Cited by 15
Nicola, F. D., Goeman, F., Pallocca, M., Sperati, F., Pizzuti, L., Melucci, E., Casini, B., Amoreo, C. A., Gallo, E., Diodoro, M. G., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0066-2 · Cited by 16
Xu, Q., Qiang, J., Huang, Z., Jiang, W., Cui, X., Hu, R.-H., Wang, T., Yi, X., Li, J., Yu, Z., et al. (2024) · Environmental Toxicology · doi:10.1002/tox.24157 · Cited by 14
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics
Taglieri, M., Gregorio, L. D., Matis, S., Uras, C. R. M., Ardy, M., Casati, S., Marchese, M., Poggi, A. D., Raffaghello, L., & Benelli, R. (2025) · Cells · doi:10.3390/cells14060457 · Cited by 13
Deak, K. L., Jackson, J., Valkenburg, K. C., Keefer, L. A., Gerding, K., Angiuoli, S. V., Datto, M., & McCall, S. J. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.07.004 · Cited by 12
Kang, L., Zhu, X., Luo, C. H., Bu, F., Zhu, J., & Zhu, Z. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.375 · Cited by 12
PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
Davis, T. B., Yang, M., Wang, H., Lee, C., Yeatman, T. J., & Pledger, W. J. (2019) · Oncotarget · doi:10.18632/oncotarget.27335 · Cited by 11
Self-citationEvaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients
Roosan, M. R., Mambetsariev, I., Pharaon, R. R., Fricke, J., Baroz, A. R., Chao, J., Chen, C., Nasser, M. W., Chirravuri‐Venkata, R., Jain, M., et al. (2021) · Cancers · doi:10.3390/cancers13112776 · Cited by 13
Escobar, D., Jones, R., Gao, J., Sun, L., Liao, J., & Yang, G. (2020) · Human Pathology · doi:10.1016/j.humpath.2020.08.002 · Cited by 11
Metadata
- Authors
- Schell, M. J., Yang, M., Teer, J. K., Lo, F. Y., Madan, A., Coppola, D., Monteiro, A. N. A., Nebozhyn, M. V., Yue, B., Loboda, A., Bien-Willner, G. A., Greenawalt, D. M., & Yeatman, T. J.
- Affiliations
- Moffitt Cancer Center (US)
- LabCorp (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Schell, Michael J.
- Yeatman, Timothy J.
- ORCID
- Venue
- Nature Communications
- Published
- 2016-06-15
- Volume
- 7
- Issue
- 1
- Pages
- 11743-11743
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4912618
- OpenAlex
- W2421455087
- Cited by
- 207
- References
- 63
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 21 · 2022: 31 · 2021: 32 · 2020: 31 · 2019: 19 · 2018: 16 · 2017: 16 · 2016: 3
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Moffitt Cancer Center (P30-CA76292)
- National Institutes of Health
- National Cancer Institute (P30‐CA76292, CA76292, U01CA157960, P30CA076292)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- colorectal cancer, APC mutation, prognostic factors, overall survival, KRAS, TP53, truncating mutations, molecular subtyping, targeted exome sequencing, treatment stratification
- MeSH terms
- Cell Nucleus, Humans, Mutation, Neoplasm Metastasis, Prognosis, Staining and Labeling, Colorectal Neoplasms, Proportional Hazards Models, Statistics, Nonparametric, Adenomatous Polyposis Coli Protein, Wnt Proteins, beta Catenin, Genes, Neoplasm, Kaplan-Meier Estimate, Microsatellite Instability, Mutation Rate, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.